The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tagrisso (Osimertinib) Market Research Report 2024
Synopsis
Due to the COVID-19 pandemic, the global Tagrisso (Osimertinib) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Tagrisso (Osimertinib) market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Tagrisso (Osimertinib) landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
40 mg accounting for % of the Tagrisso (Osimertinib) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Locally Advanced NSCLC segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Tagrisso (Osimertinib) include AstraZeneca, Incepta Pharmaceuticals Ltd, Lonza AG, Everest Pharmaceuticals, Beacon Pharmaceuticals Limited and Drug International Limited, etc. In terms of revenue, the global 3 largest players have a % market share of Tagrisso (Osimertinib) in 2021.
This report focuses on Tagrisso (Osimertinib) volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Tagrisso (Osimertinib) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America and Europe., etc.
Global Tagrisso (Osimertinib) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
40 mg
80 mg
Segment by Application
Locally Advanced NSCLC
Metastatic NSCLC
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
AstraZeneca
Incepta Pharmaceuticals Ltd
Lonza AG
Everest Pharmaceuticals
Beacon Pharmaceuticals Limited
Drug International Limited
Due to the COVID-19 pandemic, the global Tagrisso (Osimertinib) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Tagrisso (Osimertinib) market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Tagrisso (Osimertinib) landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
40 mg accounting for % of the Tagrisso (Osimertinib) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Locally Advanced NSCLC segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Tagrisso (Osimertinib) include AstraZeneca, Incepta Pharmaceuticals Ltd, Lonza AG, Everest Pharmaceuticals, Beacon Pharmaceuticals Limited and Drug International Limited, etc. In terms of revenue, the global 3 largest players have a % market share of Tagrisso (Osimertinib) in 2021.
This report focuses on Tagrisso (Osimertinib) volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Tagrisso (Osimertinib) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America and Europe., etc.
Global Tagrisso (Osimertinib) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
40 mg
80 mg
Segment by Application
Locally Advanced NSCLC
Metastatic NSCLC
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
AstraZeneca
Incepta Pharmaceuticals Ltd
Lonza AG
Everest Pharmaceuticals
Beacon Pharmaceuticals Limited
Drug International Limited
Index1 Tagrisso (Osimertinib) Market Overview
1.1 Product Overview and Scope of Tagrisso (Osimertinib)
1.2 Tagrisso (Osimertinib) Segment by Type
1.2.1 Global Tagrisso (Osimertinib) Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 40 mg
1.2.3 80 mg
1.3 Tagrisso (Osimertinib) Segment by Application
1.3.1 Global Tagrisso (Osimertinib) Sales Comparison by Application: (2022-2028)
1.3.2 Locally Advanced NSCLC
1.3.3 Metastatic NSCLC
1.3.4 Other
1.4 Global Tagrisso (Osimertinib) Market Size Estimates and Forecasts
1.4.1 Global Tagrisso (Osimertinib) Revenue 2017-2028
1.4.2 Global Tagrisso (Osimertinib) Sales 2017-2028
1.4.3 Tagrisso (Osimertinib) Market Size by Region: 2017 Versus 2021 Versus 2028
2 Tagrisso (Osimertinib) Market Competition by Manufacturers
2.1 Global Tagrisso (Osimertinib) Sales Market Share by Manufacturers (2017-2022)
2.2 Global Tagrisso (Osimertinib) Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Tagrisso (Osimertinib) Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Tagrisso (Osimertinib) Manufacturing Sites, Area Served, Product Type
2.5 Tagrisso (Osimertinib) Market Competitive Situation and Trends
2.5.1 Tagrisso (Osimertinib) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Tagrisso (Osimertinib) Players Market Share by Revenue
2.5.3 Global Tagrisso (Osimertinib) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tagrisso (Osimertinib) Retrospective Market Scenario by Region
3.1 Global Tagrisso (Osimertinib) Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Tagrisso (Osimertinib) Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Tagrisso (Osimertinib) Market Facts & Figures by Country
3.3.1 North America Tagrisso (Osimertinib) Sales by Country
3.3.2 North America Tagrisso (Osimertinib) Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Tagrisso (Osimertinib) Market Facts & Figures by Country
3.4.1 Europe Tagrisso (Osimertinib) Sales by Country
3.4.2 Europe Tagrisso (Osimertinib) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Tagrisso (Osimertinib) Market Facts & Figures by Region
3.5.1 Asia Pacific Tagrisso (Osimertinib) Sales by Region
3.5.2 Asia Pacific Tagrisso (Osimertinib) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Tagrisso (Osimertinib) Market Facts & Figures by Country
3.6.1 Latin America Tagrisso (Osimertinib) Sales by Country
3.6.2 Latin America Tagrisso (Osimertinib) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Tagrisso (Osimertinib) Market Facts & Figures by Country
3.7.1 Middle East and Africa Tagrisso (Osimertinib) Sales by Country
3.7.2 Middle East and Africa Tagrisso (Osimertinib) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Tagrisso (Osimertinib) Historic Market Analysis by Type
4.1 Global Tagrisso (Osimertinib) Sales Market Share by Type (2017-2022)
4.2 Global Tagrisso (Osimertinib) Revenue Market Share by Type (2017-2022)
4.3 Global Tagrisso (Osimertinib) Price by Type (2017-2022)
5 Global Tagrisso (Osimertinib) Historic Market Analysis by Application
5.1 Global Tagrisso (Osimertinib) Sales Market Share by Application (2017-2022)
5.2 Global Tagrisso (Osimertinib) Revenue Market Share by Application (2017-2022)
5.3 Global Tagrisso (Osimertinib) Price by Application (2017-2022)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2017-2022)
6.1.4 AstraZeneca Tagrisso (Osimertinib) Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Incepta Pharmaceuticals Ltd
6.2.1 Incepta Pharmaceuticals Ltd Corporation Information
6.2.2 Incepta Pharmaceuticals Ltd Description and Business Overview
6.2.3 Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product Portfolio
6.2.5 Incepta Pharmaceuticals Ltd Recent Developments/Updates
6.3 Lonza AG
6.3.1 Lonza AG Corporation Information
6.3.2 Lonza AG Description and Business Overview
6.3.3 Lonza AG Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Lonza AG Tagrisso (Osimertinib) Product Portfolio
6.3.5 Lonza AG Recent Developments/Updates
6.4 Everest Pharmaceuticals
6.4.1 Everest Pharmaceuticals Corporation Information
6.4.2 Everest Pharmaceuticals Description and Business Overview
6.4.3 Everest Pharmaceuticals Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Everest Pharmaceuticals Tagrisso (Osimertinib) Product Portfolio
6.4.5 Everest Pharmaceuticals Recent Developments/Updates
6.5 Beacon Pharmaceuticals Limited
6.5.1 Beacon Pharmaceuticals Limited Corporation Information
6.5.2 Beacon Pharmaceuticals Limited Description and Business Overview
6.5.3 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product Portfolio
6.5.5 Beacon Pharmaceuticals Limited Recent Developments/Updates
6.6 Drug International Limited
6.6.1 Drug International Limited Corporation Information
6.6.2 Drug International Limited Description and Business Overview
6.6.3 Drug International Limited Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Drug International Limited Tagrisso (Osimertinib) Product Portfolio
6.6.5 Drug International Limited Recent Developments/Updates
7 Tagrisso (Osimertinib) Manufacturing Cost Analysis
7.1 Tagrisso (Osimertinib) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Tagrisso (Osimertinib)
7.4 Tagrisso (Osimertinib) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Tagrisso (Osimertinib) Distributors List
8.3 Tagrisso (Osimertinib) Customers
9 Tagrisso (Osimertinib) Market Dynamics
9.1 Tagrisso (Osimertinib) Industry Trends
9.2 Tagrisso (Osimertinib) Market Drivers
9.3 Tagrisso (Osimertinib) Market Challenges
9.4 Tagrisso (Osimertinib) Market Restraints
10 Global Market Forecast
10.1 Tagrisso (Osimertinib) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Tagrisso (Osimertinib) by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Tagrisso (Osimertinib) by Type (2023-2028)
10.2 Tagrisso (Osimertinib) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Tagrisso (Osimertinib) by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Tagrisso (Osimertinib) by Application (2023-2028)
10.3 Tagrisso (Osimertinib) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Tagrisso (Osimertinib) by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Tagrisso (Osimertinib) by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Tagrisso (Osimertinib) Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
Table 2. Global Tagrisso (Osimertinib) Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
Table 3. Global Tagrisso (Osimertinib) Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Tagrisso (Osimertinib) Market Competitive Situation by Manufacturers in 2021
Table 5. Global Tagrisso (Osimertinib) Sales (K Pcs) of Key Manufacturers (2017-2022)
Table 6. Global Tagrisso (Osimertinib) Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Tagrisso (Osimertinib) Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Tagrisso (Osimertinib) Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Tagrisso (Osimertinib) Average Price (US$/Pcs) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Tagrisso (Osimertinib) Manufacturing Sites and Area Served
Table 11. Manufacturers Tagrisso (Osimertinib) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Tagrisso (Osimertinib) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tagrisso (Osimertinib) as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Tagrisso (Osimertinib) Sales by Region (2017-2022) & (K Pcs)
Table 16. Global Tagrisso (Osimertinib) Sales Market Share by Region (2017-2022)
Table 17. Global Tagrisso (Osimertinib) Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Tagrisso (Osimertinib) Revenue Market Share by Region (2017-2022)
Table 19. North America Tagrisso (Osimertinib) Sales by Country (2017-2022) & (K Pcs)
Table 20. North America Tagrisso (Osimertinib) Sales Market Share by Country (2017-2022)
Table 21. North America Tagrisso (Osimertinib) Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Tagrisso (Osimertinib) Revenue Market Share by Country (2017-2022)
Table 23. Europe Tagrisso (Osimertinib) Sales by Country (2017-2022) & (K Pcs)
Table 24. Europe Tagrisso (Osimertinib) Sales Market Share by Country (2017-2022)
Table 25. Europe Tagrisso (Osimertinib) Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Tagrisso (Osimertinib) Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Tagrisso (Osimertinib) Sales by Region (2017-2022) & (K Pcs)
Table 28. Asia Pacific Tagrisso (Osimertinib) Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Tagrisso (Osimertinib) Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Tagrisso (Osimertinib) Revenue Market Share by Region (2017-2022)
Table 31. Latin America Tagrisso (Osimertinib) Sales by Country (2017-2022) & (K Pcs)
Table 32. Latin America Tagrisso (Osimertinib) Sales Market Share by Country (2017-2022)
Table 33. Latin America Tagrisso (Osimertinib) Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Tagrisso (Osimertinib) Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Tagrisso (Osimertinib) Sales by Country (2017-2022) & (K Pcs)
Table 36. Middle East and Africa Tagrisso (Osimertinib) Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Tagrisso (Osimertinib) Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Tagrisso (Osimertinib) Revenue Market Share by Country (2017-2022)
Table 39. Global Tagrisso (Osimertinib) Sales by Type (2017-2022) & (K Pcs)
Table 40. Global Tagrisso (Osimertinib) Sales Market Share by Type (2017-2022)
Table 41. Global Tagrisso (Osimertinib) Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Tagrisso (Osimertinib) Revenue Share by Type (2017-2022)
Table 43. Global Tagrisso (Osimertinib) Price by Type (2017-2022) & (US$/Pcs)
Table 44. Global Tagrisso (Osimertinib) Sales (K Pcs) by Application (2017-2022)
Table 45. Global Tagrisso (Osimertinib) Sales Market Share by Application (2017-2022)
Table 46. Global Tagrisso (Osimertinib) Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Tagrisso (Osimertinib) Revenue Share by Application (2017-2022)
Table 48. Global Tagrisso (Osimertinib) Price by Application (2017-2022) & (US$/Pcs)
Table 49. AstraZeneca Corporation Information
Table 50. AstraZeneca Description and Business Overview
Table 51. AstraZeneca Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 52. AstraZeneca Tagrisso (Osimertinib) Product
Table 53. AstraZeneca Recent Developments/Updates
Table 54. Incepta Pharmaceuticals Ltd Corporation Information
Table 55. Incepta Pharmaceuticals Ltd Description and Business Overview
Table 56. Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 57. Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product
Table 58. Incepta Pharmaceuticals Ltd Recent Developments/Updates
Table 59. Lonza AG Corporation Information
Table 60. Lonza AG Description and Business Overview
Table 61. Lonza AG Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 62. Lonza AG Tagrisso (Osimertinib) Product
Table 63. Lonza AG Recent Developments/Updates
Table 64. Everest Pharmaceuticals Corporation Information
Table 65. Everest Pharmaceuticals Description and Business Overview
Table 66. Everest Pharmaceuticals Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 67. Everest Pharmaceuticals Tagrisso (Osimertinib) Product
Table 68. Everest Pharmaceuticals Recent Developments/Updates
Table 69. Beacon Pharmaceuticals Limited Corporation Information
Table 70. Beacon Pharmaceuticals Limited Description and Business Overview
Table 71. Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 72. Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product
Table 73. Beacon Pharmaceuticals Limited Recent Developments/Updates
Table 74. Drug International Limited Corporation Information
Table 75. Drug International Limited Description and Business Overview
Table 76. Drug International Limited Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 77. Drug International Limited Tagrisso (Osimertinib) Product
Table 78. Drug International Limited Recent Developments/Updates
Table 79. Production Base and Market Concentration Rate of Raw Material
Table 80. Key Suppliers of Raw Materials
Table 81. Tagrisso (Osimertinib) Distributors List
Table 82. Tagrisso (Osimertinib) Customers List
Table 83. Tagrisso (Osimertinib) Market Trends
Table 84. Tagrisso (Osimertinib) Market Drivers
Table 85. Tagrisso (Osimertinib) Market Challenges
Table 86. Tagrisso (Osimertinib) Market Restraints
Table 87. Global Tagrisso (Osimertinib) Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Tagrisso (Osimertinib) Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Tagrisso (Osimertinib) Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 90. Global Tagrisso (Osimertinib) Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Tagrisso (Osimertinib) Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Tagrisso (Osimertinib) Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Tagrisso (Osimertinib) Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 94. Global Tagrisso (Osimertinib) Revenue Market Share Forecast by Application (2023-2028)
Table 95. Global Tagrisso (Osimertinib) Sales Forecast by Region (2023-2028) & (K Pcs)
Table 96. Global Tagrisso (Osimertinib) Sales Market Share Forecast by Region (2023-2028)
Table 97. Global Tagrisso (Osimertinib) Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 98. Global Tagrisso (Osimertinib) Revenue Market Share Forecast by Region (2023-2028)
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tagrisso (Osimertinib)
Figure 2. Global Tagrisso (Osimertinib) Market Share by Type in 2021 & 2028
Figure 3. 40 mg Product Picture
Figure 4. 80 mg Product Picture
Figure 5. Global Tagrisso (Osimertinib) Market Share by Application in 2021 & 2028
Figure 6. Locally Advanced NSCLC
Figure 7. Metastatic NSCLC
Figure 8. Other
Figure 9. Global Tagrisso (Osimertinib) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Tagrisso (Osimertinib) Market Size (2017-2028) & (US$ Million)
Figure 11. Global Tagrisso (Osimertinib) Sales (2017-2028) & (K Pcs)
Figure 12. Tagrisso (Osimertinib) Sales Share by Manufacturers in 2021
Figure 13. Global Tagrisso (Osimertinib) Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Tagrisso (Osimertinib) Players: Market Share by Revenue in 2021
Figure 15. Tagrisso (Osimertinib) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Tagrisso (Osimertinib) Sales Market Share by Region (2017-2022)
Figure 17. Global Tagrisso (Osimertinib) Sales Market Share by Region in 2021
Figure 18. Global Tagrisso (Osimertinib) Revenue Market Share by Region (2017-2022)
Figure 19. Global Tagrisso (Osimertinib) Revenue Market Share by Region in 2021
Figure 20. United States Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Colombia Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. UAE Tagrisso (Osimertinib) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of Tagrisso (Osimertinib) by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of Tagrisso (Osimertinib)
Figure 45. Manufacturing Process Analysis of Tagrisso (Osimertinib)
Figure 46. Tagrisso (Osimertinib) Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
